Advocate Health has launched a fully integrated clinical trial network intended to embed clinical research participation into standard care for its subjects across the US.
The Advocate Health National Center for Clinical Trials network comprises 69 hospitals, more than 1,000 care locations and around six million patients.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Advocate Health reported that clinical trials can improve subject outcomes, yet many eligible individuals do not participate, and researchers are confronted with a national trial landscape that is becoming progressively more intricate and time-consuming.
Current support structures have not kept pace with this complexity, contributing to longer timelines, higher costs and slower delivery of new treatments to market.
Advocate Health National Center for Clinical Trials will address these challenges by linking participants to studies within their own communities and modernising trial operations.
The model incorporates centralised data tracking, AI-powered tools and more.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAdvocate Health CEO Eugene Woods said: “Only 5% of eligible patients across the nation participate in clinical trials. That needs to change. Today we are launching a new era for clinical trials by democratising access to the latest treatments for patients everywhere, regardless of their zip code or the size of their town.
“The Advocate Health National Center for Clinical Trials is a cornerstone of our commitment to turn innovation into impact, making it easier for patients to find and enrol in life-changing trials, and enabling innovators to deliver new treatments more efficiently through what is now the nation’s largest clinical trial network.”
Supported by Advocate Health’s academic core at Wake Forest University School of Medicine, the network already provides a single institutional review board.
It is also developing AI-based matching for connecting participants to appropriate studies, alongside platforms for real-time data capture and predictive analytics to make trials integrated, actionable and more accessible.
The centre will function across rural community clinics and academic centres. By integrating enrolment into the workflows of providers, eligible participants will be identified and enrolled easily.
Additionally, care teams will benefit from support provided by central infrastructure, along with designated trial sites that will handle coordination, logistics, and compliance tasks.
